felin
infecti
periton
fip
fatal
diseas
cat
sequela
system
felin
coronaviru
fcov
infect
mutat
viral
spike
gene
associ
fcov
found
tissu
cat
fip
fcov
found
faec
healthi
cat
implic
monocytemacrophag
tropism
system
spread
studi
design
determin
whether
gene
mutat
analysi
reliabl
diagnos
fip
cat
categoris
fip
n
without
fip
n
base
gross
postmortem
histopatholog
examin
includ
immunohistochemistri
fcov
antigen
rna
purifi
avail
tissu
fluid
faec
reversetranscriptas
quantitativepcr
rtqpcr
perform
sampl
use
fcovspecif
primer
follow
sequenc
section
gene
rtqpcr
posit
sampl
sampl
avail
total
cat
tissu
fluid
faecal
sampl
cat
fip
like
fcov
rtqpcrposit
respect
cat
without
fip
respect
identif
gene
mutat
fcov
addit
step
detect
fcov
alon
moder
increas
specif
tissu
sampl
specif
unchang
fluid
sampl
fip
diagnosi
howev
sensit
markedli
decreas
tissu
fluid
sampl
fip
diagnosi
find
demonstr
gene
mutat
analysi
fcov
substanti
improv
abil
diagnos
fip
compar
detect
fcov
alon
felin
coronaviru
fcov
infect
ubiquit
domest
cat
cat
within
multicat
household
infect
major
fcov
infect
asymptomat
associ
mild
intestin
diseas
howev
estim
infect
cat
develop
felin
infecti
periton
fip
characteris
develop
variabl
combin
pyogranulomat
polyseros
vascul
granulomat
lesion
organ
extrem
high
mortal
rate
avirul
selflimit
fcov
infect
believ
confin
intestin
know
healthi
fcovinfect
cat
implic
altern
diagnost
techniqu
investig
detect
fcov
characteris
fcov
genom
sequenc
use
pyrosequenc
sanger
sequenc
sequenc
specif
hydrolysi
probe
recent
studi
identifi
mutat
gene
encod
spike
protein
serotyp
fcov
implic
monocytemacrophag
tropism
two
amino
acid
substitut
andor
correspond
nucleotid
mutat
tc
g
respect
gene
togeth
distinguish
fcov
found
tissu
fip
cat
found
faec
healthi
cat
without
fip
case
subsequ
studi
compar
detect
fcov
rtqpcr
alon
detect
fcov
rtqpcr
combin
sequenc
analysi
confirm
presenc
nucleotid
mutat
tc
g
conclud
addit
assay
gene
mutat
analysi
alter
specif
fip
diagnosi
alreadi
decreas
sensit
serumplasma
sampl
effus
sampl
howev
shown
nucleotid
mutat
tc
g
like
marker
system
fcov
infect
rather
fip
per
se
present
fcovposit
tissu
sampl
cat
fip
fcovposit
tissu
sampl
cat
without
fip
aim
studi
analys
larger
number
tissu
fluid
faec
sampl
univers
bristol
fip
biobank
assess
use
gene
mutat
analysi
diagnosi
fip
see
figur
diagnost
pathway
use
studi
sampl
select
postmortem
tissu
sampl
faecesfaec
swab
bodi
caviti
fluid
present
excess
volum
collect
cat
euthan
suspect
fip
due
system
diseas
rare
behaviour
ground
sampl
includ
earlier
studi
collect
cerebrospin
fluid
csf
possibl
perform
immedi
follow
euthanasia
part
clinic
train
programm
independ
presenc
present
neurolog
sign
specif
evalu
possibl
age
present
sign
record
tissu
sampl
collect
rnalat
life
technolog
within
h
death
per
manufactur
instruct
store
pend
molecular
analysi
sampl
collect
neutralbuff
formalin
histolog
examin
ihc
tissu
collect
compris
primarili
mesenter
lymph
node
liver
kidney
spleen
omentum
tissu
eg
intestin
brain
lung
pericardium
pancrea
lymph
node
includ
base
gross
patholog
find
report
clinic
sign
bodi
caviti
fluid
sampl
eg
ascit
fluid
pleural
fluid
pericardi
fluid
aqueou
humour
csf
collect
plain
edtaanticoagul
blood
tube
immedi
storag
possibl
fluid
combin
rnalat
vv
upon
collect
move
longterm
storag
within
h
week
faecal
sampl
store
immedi
upon
receipt
use
formalinfix
tissu
sampl
subject
standard
process
histolog
examin
trim
routin
embed
paraffin
wax
section
prepar
stain
haematoxylineosin
confirm
fip
subject
ihc
fcov
antigen
previous
describ
cat
assign
fip
group
one
tissu
need
histopatholog
chang
consist
fip
presenc
fcov
antigen
within
lesion
macrophag
confirm
cat
assign
without
fip
group
gross
histopatholog
chang
consist
fip
need
absent
tissu
collect
includ
associ
avail
antemortem
clinic
find
eg
eye
uveiti
report
bodi
caviti
fluid
faecal
sampl
classifi
fip
without
fip
basi
classif
cat
origin
cat
fip
consid
differenti
diagnosi
base
clinic
histori
chang
support
fip
present
histolog
examin
definit
altern
diagnosi
achiev
eg
definit
diagnosi
addit
tissu
examin
histolog
inclus
within
either
fip
without
fip
group
could
made
cat
exclud
analysi
cat
sampl
collect
formalin
rnalat
also
exclud
analysi
total
rna
extract
mg
tissu
nucleospin
rna
ii
kit
machereynagel
use
method
previous
describ
total
rna
extract
bodi
caviti
fluid
mg
faec
faecal
swab
use
either
nucleospin
rna
ii
kit
use
autom
platform
chemag
instrument
perkinelm
combin
chemag
bodi
fluid
na
kit
perkinelm
elut
elut
buffer
revers
transcript
perform
use
mj
mini
gradient
thermal
cycler
improm
ii
revers
transcriptas
promega
ten
microlitr
total
rna
combin
improm
ii
reaction
buffer
mm
mgcl
dntp
mm
random
hexam
ng
improm
ii
revers
transcriptas
total
volum
follow
thermal
profil
use
min
min
min
hold
result
cdna
ad
rnasefre
water
store
randomli
select
sampl
check
inhibit
rt
reaction
use
rna
intern
amplif
control
inhibit
detect
result
shown
quantit
pcr
perform
use
gotaq
master
mix
promega
nm
forward
revers
primer
nm
taqman
probe
mm
cdna
total
volum
follow
thermal
profil
min
cycl
agil
qpcr
system
agil
technolog
primer
probe
synthes
metabion
metabion
intern
describ
previous
fluoresc
detect
nm
extens
phase
fcov
cdna
use
posit
control
rnasefre
water
neg
control
rel
fcov
copi
number
per
reaction
calcul
posit
sampl
previous
describ
sampl
posit
fcov
rtqpcr
underw
convent
pcr
amplifi
basepair
bp
dna
fragment
encompass
amino
acid
posit
protein
gene
serotyp
fcov
subsequ
pyrosequenc
amplicon
amplif
sequenc
primer
tabl
design
use
combin
pyromark
assay
design
softwar
qiagen
mfold
made
eurofin
mwg
operon
metabion
degeneraci
ad
primer
locat
primer
optimis
base
upon
sequenc
align
compris
avail
serotyp
fcov
genom
data
shown
briefli
pcr
perform
use
gotaq
master
mix
promega
nm
forward
biotinyl
revers
primer
cdna
total
volum
follow
thermal
profil
min
cycl
held
mj
mini
gradient
thermal
cycler
sampl
fail
produc
definit
sequenc
data
pyrosequenc
follow
repeat
amplif
use
pcr
protocol
cycl
amplif
pyrosequenc
perform
previous
describ
use
either
pyromark
qiagen
pyromark
qiagen
platform
dispens
order
nucleotid
defin
cgctcatg
nucleotid
posit
cgactgc
nucleotid
posit
sampl
sequenc
genotyp
nucleotid
posit
sampl
wildtyp
ie
adenin
nucleotid
posit
select
mutat
sampl
subject
sequenc
nucleotid
posit
sequenc
result
classifi
nonmut
fcov
mutat
fcov
basi
absenc
presenc
respect
nucleotid
mutat
tc
g
sampl
fail
produc
definit
pyrosequenc
data
subject
agaros
gel
wv
electrophoresi
use
ethidium
bromid
stain
easyladd
ngband
biolin
london
uk
analys
use
geldocit
imag
system
uvp
llc
cambridg
uk
confirm
singl
amplicon
correct
size
bp
produc
use
primer
pcr
describ
sampl
produc
bp
amplicon
subject
sanger
sequenc
sequenc
perform
use
nonbiotinyl
amplif
primer
standard
protocol
dna
sequenc
servic
http
wwwdnaseqcouk
sampl
posit
fcov
rtqpcr
threshold
cycl
rel
copi
number
gener
bp
amplicon
use
primer
subject
pcr
determin
presenc
serotyp
fcov
primer
design
amplifi
bp
fragment
encompass
region
protein
gene
serotyp
fcov
previous
describ
briefli
pcr
perform
use
gotaq
master
mix
promega
nm
forward
revers
primer
fcov
cdna
total
volum
follow
thermal
profil
min
cycl
min
follow
min
held
agil
thermal
cycler
agil
technolog
posit
neg
pcr
control
includ
reaction
reaction
product
separ
agaros
gel
electrophoresi
confirm
singl
amplicon
correct
size
produc
one
reaction
product
cat
subject
standard
sanger
sequenc
protocol
use
amplif
primer
sequenc
primer
data
compris
cat
identif
number
age
diagnosi
fip
vs
without
fip
sampl
type
tissu
fluid
faec
specif
organbodi
caviti
origin
applic
histopatholog
result
absenc
vs
presenc
chang
consist
fip
ihc
result
absenc
vs
presenc
fcov
antigen
lesion
fcov
rtqpcr
result
rel
fcov
copi
number
protein
mutat
analysi
result
nonmut
vs
mutat
vs
serotyp
vs
fail
enter
databas
excel
microsoft
addit
file
export
ibm
spss
statist
softwar
version
continu
variabl
within
data
set
evalu
normal
distribut
use
kolmogorovsmirnov
test
nonnorm
distribut
data
describ
median
rang
minimum
maximum
valu
popul
proport
compar
use
chi
squar
test
data
evalu
fcov
rel
copi
number
tissu
faecal
sampl
cat
without
fip
analys
use
multilevel
model
approach
mlwin
account
repeat
measur
within
cat
altern
simplifi
analysi
also
employ
nonparametr
mannwhitney
u
test
use
test
differ
cat
individu
measur
conclus
drawn
analys
full
agreement
data
shown
simpler
mannwhitney
u
test
analysi
present
rel
copi
number
compar
cat
fip
cat
without
fip
differ
sampl
type
tissu
fluid
faec
signific
assign
level
p
determin
use
combin
fcov
rtqpcr
sequenc
result
diagnosi
fip
sampl
consid
posit
result
fcov
rtqpcrposit
result
follow
detect
sampl
avail
cat
figur
definit
diagnosi
achiev
full
detail
sampl
resultsaddit
file
cat
fip
cat
without
fip
cat
exclud
five
tissu
sampl
collect
formalin
six
tissu
sampl
collect
rnalat
limit
tissu
sampl
collect
formalin
fip
could
definit
diagnos
exclud
cat
without
fip
reason
euthanasia
postmortem
diagnosi
compris
neoplasia
inflammatoryinfecti
fip
diseas
metabol
diseas
four
cardiac
immunemedi
miscellan
behaviour
ground
cat
fip
median
age
euthanasia
month
rang
month
cat
indetermin
age
cat
without
fip
median
age
euthanasia
month
rang
month
two
cat
indetermin
age
cat
without
fip
significantli
older
cat
fip
u
p
avail
tissu
sampl
median
sampl
per
cat
andor
fluid
sampl
median
sampl
per
cat
examin
per
cat
see
tabl
origin
sampl
summari
rtqpcr
result
fcov
rtqpcrposit
sampl
subject
gene
mutat
analysi
success
pyrosequenc
n
nucleotid
alon
n
nucleotid
requir
sanger
sequenc
fail
target
gene
sequenc
outcom
gene
analysi
fcov
rtqpcrposit
sampl
see
tabl
individu
result
found
addit
file
tissu
cat
fip
like
fcov
rtqpcrposit
tissu
cat
without
fip
see
tabl
vs
p
greater
rel
fcov
copi
number
median
vs
u
p
immunohistochemistri
data
avail
tissu
sampl
histopatholog
data
alon
avail
one
tissu
sampl
histopatholog
data
avail
tissu
sampl
cat
fip
cat
fip
least
one
tissu
sampl
fcov
rtqpcrposit
one
cat
sever
pyogranulomat
lymphaden
pleuriti
associ
fcov
antigen
intralesion
macrophag
consist
fip
test
neg
fcov
rtqpcr
tissu
howev
use
altern
pcr
primer
detect
fcov
three
four
tissu
sampl
avail
analysi
whilst
sequenc
reveal
mutat
rtqpcr
primer
probe
bind
site
four
tissu
sampl
three
cat
histopatholog
chang
consist
fip
posit
fcov
antigen
ihc
neg
fcov
rtqpcr
limit
focal
chang
confirm
histolog
examin
tissu
histopatholog
chang
incl
ihc
consist
fip
like
p
fcov
rtqpcrposit
without
greater
rel
fcov
copi
number
u
p
tabl
gene
mutat
analysi
perform
fcov
rtqpcrposit
sampl
fail
target
gene
sequenc
four
sampl
fail
target
gene
sequenc
collect
two
cat
analysi
tissu
sampl
indic
presenc
mutat
viru
four
sampl
low
rel
fcov
copi
number
rel
fcov
copi
number
see
tabl
twelv
sampl
fail
sequenc
five
cat
tissu
rel
fcov
copi
number
see
tabl
expect
success
sequenc
addit
pcr
sampl
reveal
presenc
serotyp
fcov
one
cat
evid
nonmut
serotyp
fcov
anoth
tissu
sampl
cat
found
serotyp
fcov
either
resid
greec
import
uk
greec
suspect
contact
cat
import
uk
greec
euthanas
suspect
fip
origin
remaind
cat
contain
within
bristol
fip
biobank
known
uk
four
tissu
sampl
three
cat
nonmut
fcov
present
mesenter
lymph
node
n
liver
n
andor
spleen
n
one
cat
mutat
fcov
anoth
tissu
sampl
one
cat
mutat
nonmut
fcov
detect
tissu
one
cat
serotyp
fcov
anoth
tissu
sampl
ten
tissu
sampl
three
cat
sequenc
data
consist
presenc
nonmut
mutat
nucleotid
tc
fcov
compris
mesenter
lymph
node
n
liver
n
omentum
n
spleen
n
lung
n
kidney
n
one
cat
nonmut
fcov
sequenc
anoth
tissu
sampl
one
cat
mutat
fcov
detect
tissu
two
tissu
sampl
one
cat
sequenc
data
consist
presenc
either
nonmut
doublemut
nucleotid
g
sampl
fcov
type
mutat
fcov
compris
omentum
spleen
n
also
mutat
fcov
detect
anoth
tissu
mix
fcov
characteris
ie
doubl
singl
mutant
mutat
fcov
detect
sampl
mutat
nucleotid
n
nucleotid
c
n
mix
nucleotid
c
n
four
mutat
five
cat
differ
mutat
detect
differ
tissu
cat
without
fip
least
one
tissu
posit
fcov
rtqpcr
ihc
neg
cat
avail
cat
unstabl
diabet
histopatholog
find
suggest
fip
histopatholog
ihc
data
avail
tissu
sampl
histopatholog
data
alon
avail
tissu
sampl
cat
without
fip
histopatholog
examin
find
chang
suggest
fip
ihcneg
sampl
avail
ihc
percent
fcov
rtqpcrposit
see
tabl
fcov
rtqpcrposit
sampl
three
fail
gene
mutat
analysi
collect
three
cat
cat
low
rel
fcov
copi
number
see
tabl
two
tissu
sampl
nonmut
fcov
present
compris
colon
brain
one
cat
pyothorax
pyogranulomat
bronchopneumonia
tabl
origin
sampl
rtqpcr
result
threshold
cycl
valu
one
sampl
obtain
cerebellomedullari
cistern
one
sampl
collect
lumbar
subarachnoid
space
also
mutat
fcov
liver
one
sampl
colon
one
cat
central
nervou
system
cn
astrocytoma
sequenc
data
consist
presenc
nonmut
mutat
fcov
tissu
fcov
rtqpcrposit
mutat
fcov
detect
sampl
mutat
nucleotid
n
nucleotid
c
n
none
mix
failur
n
low
copi
number
n
includ
tissu
sampl
histopatholog
chang
consist
fip
cat
definit
diagnos
fip
base
analysi
addit
tissu
immunohistochemistri
neg
posit
fcov
rtqpcr
fluid
cat
fip
like
p
fcovposit
n
compar
fluid
cat
without
fip
n
posit
sampl
cat
without
fip
n
compar
copi
number
one
cat
csf
collect
lumbar
cistern
site
fcov
rtqpcrposit
cistern
sampl
rel
fcov
copi
number
neg
lumbar
sampl
brain
spinal
cord
cat
avail
histolog
examin
one
fcov
rtqpcrposit
sampl
pleural
fluid
lost
analysi
remain
fcov
rtqpcrposit
sampl
five
fail
target
gene
sequenc
one
sampl
pericardi
fluid
collect
cat
mutat
fcov
detect
tissu
sampl
low
rel
fcov
copi
number
see
tabl
four
abdomin
fluid
four
cat
rel
fcov
copi
number
see
tabl
expect
success
sequenc
analysi
reveal
presenc
serotyp
fcov
four
cat
also
serotyp
fcov
detect
tissu
sampl
four
fluid
sampl
nonmut
fcov
detect
compris
abdomin
fluid
n
pleural
fluid
n
three
cat
two
mutat
fcov
tissu
sampl
one
nonmut
mix
mutat
fcov
tissu
sampl
four
sampl
sequenc
data
consist
presenc
nonmut
mutat
fcov
fluid
three
cat
abdomin
n
pleural
n
unknown
origin
n
cat
mutat
fcov
tissu
sampl
mutat
fcov
detect
sampl
mutat
nucleotid
n
nucleotid
c
n
one
mutat
one
sampl
abdomin
fluid
cat
sever
interstiti
pneumonia
found
fcov
rtqpcrposit
low
level
rel
fcov
copi
number
see
tabl
sequenc
reveal
mutat
nucleotid
c
fcov
cytolog
analysi
sampl
perform
cat
also
low
rel
fcov
copi
number
sampl
lung
tissu
gene
mutat
faec
cat
fip
like
p
fcov
rtqpcrposit
compar
cat
without
fip
differ
rel
copi
number
u
p
fip
median
rang
nonfip
median
rang
pcr
two
sampl
fail
sequenc
reveal
presenc
serotyp
fcov
cat
also
serotyp
fcov
detect
tissu
fluid
sampl
sampl
sequenc
fail
low
rel
fcov
copi
number
see
tabl
sensit
specif
accuraci
identif
fcov
rtqpcr
alon
rtqpcr
combin
subsequ
detect
serotyp
mutat
fcov
diagnosi
fip
see
tabl
signific
differ
cat
fip
cat
without
referencestandard
diagnosi
fip
consid
identif
fcov
antigen
immunohistochemistri
least
one
tissu
associ
appropri
histopatholog
chang
cat
consid
without
fip
fip
exclud
diagnosi
posit
sampl
without
histopatholog
data
subject
sequenc
sampl
histopatholog
data
avail
includ
calcul
b
rtqpcr
combin
spike
protein
sequenc
characteris
fcov
c
one
sampl
lost
analysi
fip
proport
mutat
fcov
detect
fcov
rtqpcrposit
tissu
fluid
sampl
vs
p
total
tissu
fluid
faec
sampl
analys
cat
fip
without
fip
mark
increas
number
sampl
analys
compar
previou
studi
contain
similar
number
effus
sampl
two
previou
studi
studi
examin
use
fcov
rtpcr
alon
diagnosi
fip
use
fluid
sampl
studi
compar
fcov
rtpcr
fcov
rtpcr
combin
characteris
gene
mutat
diagnosi
fip
use
bodi
caviti
fluid
deriv
similar
sensit
fcov
rtpcr
alon
fcov
rtpcr
gene
mutat
characteris
specif
fcov
rtpcr
alon
fcov
rtpcr
gene
mutat
characteris
obtain
studi
sensit
fcov
rtpcr
alon
fcov
rtpcr
gene
mutat
characteris
specif
respect
expect
cat
histolog
chang
consist
fip
individu
tissu
without
fip
lesion
like
fcov
rtqpcrneg
lower
copi
number
tissu
fip
lesion
present
overal
howev
fcov
rtqpcr
sensit
vs
calcul
tabl
ihc
detect
fcov
tissu
cat
fip
therefor
surprisingli
maximis
sensit
ihc
rtqpcr
detect
fcov
cat
fip
biopsi
collect
tissu
imag
chang
gross
visual
chang
consist
granulomata
lesion
site
whenev
possibl
distribut
granulomat
lesion
within
tissu
viru
laden
macrophag
within
lesion
uniform
could
account
failur
detect
viral
antigen
fip
lesion
neg
fcov
rtqpcr
result
cat
combin
histolog
ihc
examin
confirm
fip
howev
applic
calcul
sensit
suspect
fip
case
view
caution
sampl
includ
studi
select
basi
clinic
sign
gross
patholog
chang
contrast
tissu
sampl
cat
without
fip
posit
fcov
rtqpcr
result
even
though
neither
histolog
chang
consist
fip
evid
viral
antigen
express
tissu
macrophag
ihc
result
specif
fcov
rtqpcr
compar
refer
standard
ihc
persist
fcov
intestin
extraintestin
tissu
macrophag
absenc
diseas
report
healthi
cat
experiment
infect
fcov
albeit
author
report
ihc
rel
insensit
method
fcov
detect
compar
rtqpcr
two
previou
studi
cerebrospin
fluid
evalu
sampl
collect
cerebellomedullari
cistern
one
studi
evalu
use
immunocytochemistri
diagnosi
fip
sampl
combin
sensit
specif
studi
evalu
use
rtqpcr
diagnosi
fip
sensit
specif
percent
result
latter
studi
compar
current
studi
sensit
specif
howev
appar
effect
site
cerebrospin
fluid
collect
diagnost
sensit
fcov
infect
warrant
investig
cat
fip
may
concern
clinic
sign
could
relat
increas
intracrani
pressur
lumbar
sampl
could
provid
lower
risk
herniat
cf
cistern
sampl
howev
fip
lesion
rare
go
beyond
leptomening
brain
stem
unpublish
result
detect
fcov
rtqpcr
colon
tissu
cat
without
fip
surpris
enter
infect
describ
otherwis
clinic
healthi
cat
cat
euthan
result
clinic
sign
relat
pyothorax
brain
tumour
nasal
adenocarcinoma
unremark
histopatholog
examin
neg
ihc
colon
tissu
cat
faec
avail
test
detect
viral
shed
cat
fcov
nonmut
anoth
cat
mutat
fcov
remain
cat
mix
nonmut
mutat
fcov
detect
note
cat
pyothorax
also
nonmut
viru
detect
low
level
brain
mutat
viru
detect
low
level
liver
suggest
viraem
time
death
viru
persist
colon
also
extraintestin
tissu
macrophag
colon
tissu
sampl
exclud
one
tissu
sampl
nonfip
cat
fcov
rtqpcrposit
sequenc
data
avail
n
mutat
fcov
confirm
previou
find
gene
mutat
marker
system
spread
falseneg
fcov
rtqpcr
result
possibl
due
high
rate
fcov
genom
mutat
could
result
ineffici
bind
primer
andor
probe
site
sampl
fcov
rtqpcrposit
result
pyrosequenc
perform
fcov
rtqpcrneg
result
confirm
howev
fals
neg
rtqpcr
result
consid
uncommon
detect
cat
confirm
fip
studi
least
one
tissu
cat
posit
possibl
calcul
rel
fcov
copi
number
studi
overestim
viral
load
fcov
rtqpcr
assay
amplifi
cellassoci
subgenom
mrna
well
cellassoci
virionassoci
genom
rna
rel
abund
determin
posit
primer
viral
transcript
start
end
fcov
genom
subgenom
mrna
contain
viral
sequenc
contain
viral
sequenc
henc
assay
direct
end
genom
eg
viral
replicas
complex
gene
less
suscept
viral
load
overestim
direct
end
genom
eg
accessori
protein
gene
rtqpcr
assay
use
present
studi
target
region
span
membranenucleocapsid
gene
junction
nucleotid
posit
fcov
isol
fipv
overestim
less
issu
faecal
sampl
firstli
faec
high
level
bacteria
thu
rich
rnase
would
degrad
rna
releas
cell
shed
gut
lumen
secondli
viral
rna
like
present
virion
form
contain
subgenom
mrna
protect
rnase
degrad
viral
envelop
cellassoci
viral
rna
like
degrad
due
cell
death
abund
rnase
studi
determin
whether
faecal
shed
fcov
infect
import
concept
faec
contain
mutat
fcov
theoret
increas
potenti
caus
fip
follow
faecoor
transmiss
assum
mutat
viru
enter
enterocyt
replic
previou
studi
report
fcov
detect
tissu
cat
fip
loss
gene
function
associ
loss
abil
replic
enterocyt
therefor
infect
via
natur
rout
enterocyt
cell
cultur
use
accur
assess
fcov
infect
viru
copi
number
recent
studi
howev
use
enterocyt
cell
cultur
possibl
studi
gene
sequenc
attempt
calcul
accuraci
author
consid
import
includ
sampl
gene
mutat
analysi
fail
accur
reflect
clinic
situat
failur
identifi
presenc
mutat
fcov
may
consid
lack
support
diagnosi
fip
abl
obtain
pyrosequenc
data
sampl
attribut
low
rel
fcov
copi
number
failur
amplif
primer
bind
failur
pyrosequenc
primer
bind
viral
cdna
result
sequenc
mismatch
convent
sequenc
pyrosequenc
amplicon
possibl
case
pyrosequenc
fail
n
sampl
pyrosequenc
attempt
signific
secondari
structur
predict
amplicon
pyrosequenc
primer
bind
site
could
account
failur
pyrosequ
mix
nonmut
mutat
fcov
infect
may
also
miss
pyrosequenc
assay
amplif
step
bias
detect
sequenc
toward
domin
viru
type
addit
serotyp
serotyp
fcov
associ
develop
fip
howev
mutat
within
protein
fusion
peptid
preval
serotyp
fcov
associ
system
infect
develop
fip
recombin
event
result
format
serotyp
fcov
includ
protein
gene
assay
characteris
portion
genom
applic
serotyp
fcov
therefor
predict
pyrosequenc
would
fail
sampl
contain
serotyp
fcov
howev
serotyp
fcov
detect
rtqpcr
assay
use
studi
assay
target
section
genom
affect
recombin
event
studi
cat
fail
pyrosequenc
assess
presenc
serotyp
fcov
therefor
exclud
cat
dual
infect
serotyp
spike
gene
mutat
analysi
combin
fcov
rtqpcr
result
modest
increas
specif
offset
decreas
sensit
result
decreas
accuraci
independ
diseas
preval
within
popul
signific
differ
proport
mutat
fcov
detect
tissu
bodi
caviti
fluid
sampl
cat
fip
cat
without
fip
fcov
rtqpcrposit
p
overal
combin
fcov
rtqpcr
protein
mutat
analysi
enhanc
diagnosi
fip
fcov
rtqpcr
alon
gene
mutat
analysi
signific
time
cost
implic
previous
propos
substitut
could
affect
fusogen
activ
cell
receptor
specif
fcov
protein
permit
entri
macrophag
monocyt
propos
addit
fcov
mutat
along
chang
within
host
immunolog
respons
requir
permit
seemingli
uncontrol
replic
seen
develop
fip
hypothes
support
present
studi
firstli
find
major
fcov
detect
tissu
sampl
cat
fip
cat
without
fip
substitut
fcov
protein
secondli
also
describ
previou
studi
natur
infect
cat
find
fcov
rna
detect
far
greater
proport
tissu
sampl
cat
fip
tissu
sampl
cat
without
fip
sampl
rtqpcr
posit
significantli
higher
fcov
rel
copi
number
found
fip
sampl
median
vs
u
p
viral
genom
mutat
also
associ
fip
evalu
part
studi
exampl
mutat
protein
gene
encod
amino
acid
differ
furin
cleavag
motif
heptad
region
subunit
correl
diseas
truncat
accessori
protein
gene
also
associ
loss
abil
replic
within
enterocyt
report
fipassoci
fcov
howev
characteris
viral
genom
mutat
within
aim
studi
use
viral
genom
mutat
diagnosi
fip
far
suggest
studi
limit
includ
lack
cytolog
data
fluid
sampl
perform
retrospect
store
sampl
consist
perform
time
collect
due
lack
clinic
justif
euthanas
cat
howev
number
studi
examin
use
immunocytochemistri
fluid
diagnosi
fip
report
similar
sensit
diagnosi
fip
fcov
rtqpcr
use
studi
observ
increas
fals
posit
result
result
reduc
specif
howev
experi
fals
posit
result
relev
issu
provid
suffici
cell
number
examin
achiev
cell
concentr
cytospin
fluid
use
prepar
formalinfix
paraffin
embed
cell
pellet
treat
like
tissu
specimen
ihc
unpublish
observ
anja
kipar
addit
pyrosequenc
use
target
small
region
serotyp
fcov
genom
univers
bristol
fip
biobank
cat
includ
studi
repres
conveni
popul
includ
cat
fip
necessarili
differenti
diagnosi
cat
sampl
avail
necessarili
reflect
clinic
sign
report
clinic
relev
sampl
tissu
essenti
definit
diagnosi
may
includ
differ
cat
fip
cat
without
fip
conveni
popul
clearli
demonstr
age
diagnosi
compar
reflect
diseas
cat
euthanas
neoplasia
common
reason
euthanasia
significantli
older
cat
without
fip
signific
differ
age
could
complic
comparison
faecal
fcov
shed
clinic
group
nonfip
vs
fip
group
younger
cat
like
recent
expos
factor
could
increas
likelihood
enter
fcov
infect
multicat
household
ie
breed
catteri
rehom
shelter
one
studi
found
fcov
shed
common
young
cat
cat
age
week
cf
cat
week
howev
anoth
studi
faecal
fcov
shed
found
differ
differ
age
categori
year
age
year
year
ideal
cat
without
fip
would
age
clinic
sign
match
cat
fip
howev
possibl
gener
difficult
achiev
unbias
clinic
patient
cohort
previou
casecontrol
studi
fip
either
report
age
either
fip
control
cat
popul
recruit
healthi
control
cat
one
advantag
increas
age
cat
without
fip
impli
cat
would
unlik
gone
develop
fip
concurr
diseas
result
euthanasia
absenc
clinic
relev
sampl
tissu
cat
result
exclus
analysi
definit
diagnosi
could
achiev
earlier
studi
use
methodolog
present
data
suggest
presenc
substitut
fcov
protein
indic
system
spread
fcov
definit
marker
develop
fip
albeit
less
common
mutat
fcov
cat
fip
mutat
fcov
may
detect
cat
without
fip
nonmut
fcov
may
detect
cat
fip
despit
slight
increas
specif
tissu
sampl
addit
gene
mutat
analysi
detect
fcov
rtqpcr
sampl
cat
help
differenti
cat
without
fip
henc
aid
clinic
diagnosi
fip
abbrevi
bp
base
pair
ccov
canin
coronaviru
cn
central
nervou
system
csf
cerebrospin
fluid
fcov
felin
coronaviru
fip
felin
infecti
periton
ihc
immunohistochemistri
rtqpcr
revers
transcriptas
quantit
polymeras
chain
reaction
protein
spike
protein
addit
file
cat
code
age
month
diagnosi
fip
without
fip
sampl
type
tissu
fluid
faec
sampl
origin
histopatholog
result
absenc
presenc
chang
consist
fip
ihc
result
absenc
presenc
fcov
antigen
lesion
fcov
rtqpcr
threshold
cycl
rel
copi
number
protein
mutat
analysi
result
na
applic
nd
perform
unknown
